Contact details

Tom Page

T: +44 20 7809 2021 M: +44 7813 600 516 Email Tom | vCard Office: London

Awards

ECM-small-midcap

ECM-small-midcap

Tom Page Partner

Contact details

Tom Page

Tom Page
Partner

T: +44 20 7809 2021 M: +44 7813 600 516 Email Tom | vCard Office: London

Tom has extensive experience advising on all aspects of corporate finance including capital markets, takeovers and M&A. Clients value Tom's pragmatic and commercial approach and his ability to guide clients smoothly through transactions.
  • Profile
  • Services
  • Sectors

Tom's practice includes advising clients on IPOs, Code takeovers, private company M&A including mid and large cap and cross border transactions, restructuring and joint ventures.

He has particular experience advising mid-cap investment banks and working on transactions in the life sciences sector.

Tom is consultant co-editor of "A Practitioner's Guide to the AIM Rules" published by Sweet & Maxwell.

"Tom Page is always a pleasure to work with and can be relied upon to give excellent balanced advice."

The Legal 500 UK 2022

  • Public and private M&A
  • Restructuring and insolvency
  • Joint ventures
  • Equity capital markets
  • Corporate

easyHotel

Advised easyHotel on its £139 million takeover.

BTG plc

Advised on the £177 million takeover of Biocompatibles plc.

Kalibrate

Advised Kalibrate Technologies on its £29 million takeover by Hanover Active Equity Fund.

Whitewash and advisory

Advised on various Code whitewashes and advisory work.

De Vere

Advised on the sale of the Grand Hotel, Brighton.

Feedback plc

Advised Feedback plc on acquisitions of Cambridge Computed Images Ltd and TexRAD Ltd.

AIM Group Ltd

Sale of US operations and UK holding company of aviation manufacturing company to buyer backed by Liberty Hall Capital for US$220 million.

AIM Group Plc

Advised on the sale of this specialist manufacturer of aircraft interiors to management, backed by Lloyds Development Capital

Gentoo Group

Advised on its acquisition of the assets of AIM listed Romag Holdings plc by way of a pre-pack administration.

The Pension Protection Fund

Advised on various matters including the restructuring of Monarch Airlines.

BTG plc

Advised in relation to the pre-pack acquisition of certain assets of SCM Pharma.

JP Morgan

Advised JP Morgan on its container ship joint venture with global shipping company Bernhard Schulte.

Maas Capital

Advised in relation to a joint venture in the offshore sub sector.

International shipowner

Advised on its entry into and exit from a VLGC owning joint venture.

Manolete Partners

Advised Manolete Partners on its £76m AIM IPO and placing.

BTG

Advised BTG plc on its £160m joint underwritten cash box placing in connection with the acquisition of PneumRx, Inc.

Numis and Hornby

Advised Numis in relation to Hornby’s placing and move from the main market to AIM.

Novacyt

Advised Paris-listed medical diagnostics company Novacyt on its dual listing on AIM.

Hotel Chocolat

Advised Hotel Chocolat on its AIM IPO and secondary fundraising.

Northland

Advised Northland on its role as Nomad to Evgen Pharmaceuticals on its AIM IPO.

Numis and Argentex Group

Advised Numis in its role as nominated adviser and broker on the AIM IPO of Argentex Group plc and related £46 million placing of new and existing shares.

easyHotel plc

Advised easyHotel on its AIM IPO, subsequent secondary fundraisings, takeover and de-listing.

finnCap

Advised finnCap on its role as Nomad and broker to KRM22 on its AIM IPO.

NetScientific

Advised NetScientific plc on its acquisition of EMV Capital Limited and placing, including a Rule 9 waiver.

Oriel

Advised Oriel in its role as Nomad and broker to Rex Bionics, provider of electronic mobility devices, in relation to an acquisition and its re-admission to AIM.

BTG plc

Advised BTG plc on the joint underwritten cash box placing in connection with the acquisition of PneumRx, Inc.

Advised BTG plc on the £177 million takeover of Biocompatibles plc.

De Vere

Advised De Vere on the sale of the Grand Hotel, Brighton.

Numis Securities

Advised Numis Securities in relation to Hornby plc's placing and move from the main market to AIM.

Kalibrate Technologies plc

Advised Kalibrate Technologies plc on its admission to trading on AIM.

More: Corporate
  • Life sciences
  • Technology

Tom is a corporate lawyer with particular experience in the life sciences sector. He advises on equity capital markets transactions, including IPOs and secondary fundraisings, private M&A and public takeovers. Tom acts for private and listed companies and for life sciences teams at brokers and investment banks. Clients value Tom’s pragmatic and commercial approach and his ability to guide them smoothly through transactions.

Tom’s life sciences experience includes advising:

BTG

Advised in relation to its joint underwritten cash box placing in connection with the acquisition of PneumRx, Inc

Novacyt SA

Advised Novacyt SA, a French incorporated diagnostics company with HQ in the UK, on its AIM IPO which constituted a dual listing with the existing listing on Euronext Growth Paris

Northland Capital Partners

Advised in its role as Nomad and broker to Evegen Pharma on its AIM IPO

A FTSE 250 healthcare company

Advised in relation to a private acquisition of a university spin out.

Multi-jurisdictional joint venture

Advised in relation to a multi-jurisdictional joint venture over Finnish pharmaceuticals company

Oriel

Advised in its role as Nomad and broker to Rex Bionics, provider of electronic mobility devices, in relation to an acquisition and re-admission to AIM

BTG

Advised on the pre-pack acquisition of assets of SCM Pharma

BTG

Advised on its £177 million takeover of Biocompatibles plc by way of scheme of arrangement

NetScientific

Advised on its acquisition, placing and Rule 9 waiver

More: Life sciences

Kalibrate Technologies Plc

Advised in connection with AIM IPO of Kalibrate Technologies Plc, a provider of proprietary software-based products and services to the global petroleum retail industry, and in connection with its subsequent recommended takeover.

Nomad

Advised Nomad in connection with acquisition and readmission to AIM of Rex Bionics, pioneer of the REX Robot technology that enhances the mobility of wheel-chair users and on its subsequent secondary placing.

Nomad

Advised Nomad and joint brokers in connection with AIM IPO of BPO company, Ibex Global Solutions.

More: Technology

Awards

ECM-small-midcap

ECM-small-midcap

Latest news & insights

13 Sep 2023

From News

Stephenson Harwood advises Novacyt on Yourgene Health takeover

Law firm Stephenson Harwood LLP has advised long-standing diagnostics client Novacyt S.A. in relation to its recommended takeover of Yourgene Health plc

More

05 Sep 2023

From News

Stephenson Harwood advises Flarin on fundraise

Law firm Stephenson Harwood LLP has advised Flarin, the joint pain relief brand, on its fundraise through existing investor IW Capital and through ITV's Media for Equi..

More

24 Mar 2023

From Insights

Life sciences podcast

The Stephenson Harwood life sciences podcast provides an overview of key legal developments relating to the sector.

More

13 Mar 2023

From News

Stephenson Harwood's response to recent news regarding Silicon Valley Bank

Having spent the weekend supporting clients reacting to the bank's potential collapse in the UK, Stephenson Harwood is pleased to hear the latest news this morning con..

More

23 Jan 2023

From Insights

Life sciences A to Z - H is for hungry capital companies - life sciences businesses and the new Pre-Emption Group Principles

The Financial Reporting Council ("FRC") has issued a new Statement of Principles (the "Principles") on behalf of the Pre-Emption Group ("PEG") which apply to listed co..

More

03 Aug 2021

From Insights

Changes to the Listing Rules - SPACs

SPAC stands for "special purpose acquisition company" which is a newly incorporated company with no business operations that is formed to raise capital through an IPO ..

More

28 Jul 2021

From News

Stephenson Harwood advises Hotel Chocolat on £40 million fundraising

Law firm Stephenson Harwood LLP has advised British chocolatier Hotel Chocolat Group plc on its £40 million fundraising by way of a secondary placing of new ordinary s..

More

12 Jan 2021

From Insights

A view from the practitioners: AIM at 25 podcast

In this podcast members of the Stephenson Harwood capital markets team talk to some of contributing authors to the Practitioner’s Guide to the AIM Rules

More

02 Nov 2020

From News

Stephenson Harwood partners edit leading AIM guide

Stephenson Harwood partners Tom Nicholls and Tom Page were consultant editors for the eighth edition of ‘A Practitioner's Guide to the AIM Rules’, which was published ..

More

13 Jul 2020

From Insights

COVID-19 considerations for life sciences M&A

This note sets out some COVID-19 considerations for M&A which are specific to the life sciences sector.

More

29 Apr 2020

From Insights

Equity fundraising considerations for AIM companies during COVID-19

COVID-19 and related business challenges have forced many companies to review their balance sheets and particularly their cash positions. Many AIM listed companies hav..

More

23 Mar 2020

From News

Stephenson Harwood advises Hotel Chocolat on £22 million fundraising

Law firm Stephenson Harwood LLP has advised British chocolatier Hotel Chocolat on its £22 million placing through the issue of 9.78 million new ordinary shares at 225 ..

More

28 Aug 2019

From News

Stephenson Harwood advises on £139 million takeover of easyHotel

Law firm Stephenson Harwood LLP is advising easyHotel on its £139 million takeover by a consortium consisting of Ivanhoé Cambridge and ICAMAP Investments.

More

23 Jul 2019

From Insights

The new Prospectus Regulation

The European Union’s new Prospectus Regulation1 came into force on 20 July 2017, however the bulk of the changes it brings to the existing prospectus regime were imple..

More

print-footer
logo
© Stephenson Harwood LLP 2016. Any reference to Stephenson Harwood in this document means Stephenson Harwood LLP and/or its affiliated undertakings. Any reference to a partner is used to refer to a member of Stephenson Harwood LLP.